<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671914</url>
  </required_header>
  <id_info>
    <org_study_id>Intrauterine adhesions 2020</org_study_id>
    <nct_id>NCT04671914</nct_id>
  </id_info>
  <brief_title>Prevalence of Intrauterine Adhesions After D&amp;C With or Without Antiadhesion Gel After Abortion in Second Trimester.</brief_title>
  <acronym>ADAB</acronym>
  <official_title>Prevalence of Intrauterine Adhesions After the Application of Hyaluronic Acid Gel After Dilatation and Curettage in Women With Spontaneous Abortion or Induction of Abortion From 12+0 Till 23+6 Week of Pregnancy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute for the Care of Mother and Child, Prague, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bulovka Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital, Prague</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute for the Care of Mother and Child, Prague, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Only patients who sign an informed consent will be included. Patients after a miscarriage in&#xD;
      the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine&#xD;
      cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two groups. In the&#xD;
      first group, RCUI will be performed according to current standards. In the second group, an&#xD;
      anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will be applied to the&#xD;
      uterine cavity at the end of the RCUI procedure. Eight to twelve weeks after the operation,&#xD;
      the occurrence of adhesions will be evaluated by ultrasound examination and diagnostic&#xD;
      hysteroscopy (if adhesions will be detected, they will be disrupted). The study will also&#xD;
      include the completion of a questionnaire in terms of the frequency and strength of the&#xD;
      menstrual cycle. The presence of adhesions will be assessed according to The American&#xD;
      Fertility Society (AFS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methodology Only patients who sign informed consent will be included. Patients after a&#xD;
      miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of&#xD;
      the uterine cavity (RCUI, revisio cavi uteri instrumentalis) will be randomized into two&#xD;
      groups. In the first group, RCUI will be performed according to current standards. In the&#xD;
      second group, an anti-adhesive preparation with hyaluronic acid (Hyalobarrier gel Endo) will&#xD;
      be applied to the uterine cavity at the end of the RCUI procedure. Eight to twelve weeks&#xD;
      after the operation, the occurrence of adhesions will be evaluated by ultrasound examination&#xD;
      and diagnostic hysteroscopy (if adhesions will be detected, they will be disrupted). The&#xD;
      study will also include the completion of a questionnaire in terms of the frequency and&#xD;
      strength of the menstrual cycle. The presence of adhesions will be assessed according to The&#xD;
      American Fertility Society (AFS).&#xD;
&#xD;
      Expected number of enrolled subjects: a total of 200 patients, 100 in each branch Entry&#xD;
      criteria: Adult (18 to 40 years old) women with a wish for future pregnancy, abortion in the&#xD;
      2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the&#xD;
      uterine cavity (RCUI), signed informed consent&#xD;
&#xD;
      Exclusion criteria: age below 18 years, age over 40 years, history of previous uterine&#xD;
      surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine&#xD;
      adhesions), suspicion of molar pregnancy, signs of pelvic infection, disagreement with&#xD;
      participation in the study&#xD;
&#xD;
      Primary goals of the project:&#xD;
&#xD;
        1. determination of the frequency of intrauterine adhesions in women who underwent&#xD;
           instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis)&#xD;
           after abortion in the 2nd trimester of pregnancy&#xD;
&#xD;
        2. to determine whether the application of an antiadhesive agent with hyaluronic acid has&#xD;
           an effect on the frequency of intrauterine adhesions after this procedure&#xD;
&#xD;
      A similar prospective randomized multicenter study investigating the relationship of&#xD;
      intrauterine adhesions using an intrauterine gel with hyaluronic acid was published in 2017&#xD;
      by Hooker. Patients were enrolled in the study up to the 14th week of pregnancy. The&#xD;
      incidence of intrauterine adhesions was statistically lower in the hyaluronic acid group&#xD;
      compared to the no treatment group (13% vs. 30.6%, RR 0.43, 95% CI 0.22-0.83, p 0.013).&#xD;
      However, this study investigated RCUI in the first trimester of pregnancy. Our study is to&#xD;
      our knowledge the first with a focus on the second trimester RCUI.&#xD;
&#xD;
      Secondary goals of the project:&#xD;
&#xD;
        1. number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both&#xD;
           groups&#xD;
&#xD;
        2. number of term pregnancies in the 24 months after RCUI in both groups&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter prospective controlled study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Participant will not be informed about usage of hyalobarier gel or not. Care provider - at the time of RCUI the surgeon will know from randomisation if apply the gel or not. The investigator performing evaluation of adhesions by hysteroscopy will be blinded to the arm which the participants belong to.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Intrauterine adhesions after D&amp;C and intrauterine application of hyaluronic acid gell.</measure>
    <time_frame>3 month</time_frame>
    <description>To find out wheter the application of antiadhesive agent with hyaluronic acid has an effect on the frequency of intrauterine adhesions after this procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of Intrauterine adhesions after D&amp;C.</measure>
    <time_frame>3 month</time_frame>
    <description>Dermination of the frequency of intrauterine adhesions in women who underwent instrumental revision of the uterine cavity (RCUI, revisio cavi uteri instrumentalis) after abortion in the 2nd trimester of pregnancy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>24 month</time_frame>
    <description>Number of pregnancies (pregnancy rate) in the period of 24 months after RCUI in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery rate</measure>
    <time_frame>24 month</time_frame>
    <description>Number of term deliveries in the 24 months after RCUI in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Asherman Syndrome</condition>
  <condition>Abortion Late</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid gel after D&amp;C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After abortion in the II trimester, we provide D&amp;C and after the procedure, we apply in uterine cavity Hyaluronic acid gel.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Only D&amp;C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After abortion, in the II trimester, we provide only D&amp;C.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic Acid 20 MG/ML Injectable Solution</intervention_name>
    <description>Application of hyaluronic acid gel into uterine cavity after After abortion in II trimester we do D&amp;C</description>
    <arm_group_label>Hyaluronic acid gel after D&amp;C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dilation and curretage</intervention_name>
    <description>After abortion in II trimester we do D&amp;C.</description>
    <arm_group_label>Hyaluronic acid gel after D&amp;C</arm_group_label>
    <arm_group_label>Only D&amp;C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult (18 to 40 years) women with a wish for future pregnancy&#xD;
&#xD;
          -  abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with&#xD;
             instrumental revision of the uterine cavity (RCUI)&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age below 18 years, age over 40 years&#xD;
&#xD;
          -  history of previous uterine surgery (myomectomy, resection of the intrauterine septum,&#xD;
             disruption of intrauterine adhesions)&#xD;
&#xD;
          -  suspected molar pregnancy&#xD;
&#xD;
          -  signs of pelvic infection&#xD;
&#xD;
          -  disagreement with participation in the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiri Hanacek, MD, Ph.D.</last_name>
    <phone>+420604154736</phone>
    <email>jiri.hanacek@upmd.eu</email>
  </overall_contact>
  <results_reference>
    <citation>Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003 Mar;79(3):577-84.</citation>
    <PMID>12620443</PMID>
  </results_reference>
  <results_reference>
    <citation>Rai R, Regan L. Recurrent miscarriage. Lancet. 2006 Aug 12;368(9535):601-11. Review.</citation>
    <PMID>16905025</PMID>
  </results_reference>
  <results_reference>
    <citation>ASHERMAN JG. Amenorrhoea traumatica (atretica). J Obstet Gynaecol Br Emp. 1948 Feb;55(1):23-30.</citation>
    <PMID>18902559</PMID>
  </results_reference>
  <results_reference>
    <citation>Hooker AB, de Leeuw R, van de Ven PM, Bakkum EA, Thurkow AL, Vogel NEA, van Vliet HAAM, Bongers MY, Emanuel MH, Verdonkschot AEM, Br√∂lmann HAM, Huirne JAF. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril. 2017 May;107(5):1223-1231.e3. doi: 10.1016/j.fertnstert.2017.02.113. Epub 2017 Apr 6.</citation>
    <PMID>28390688</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>December 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asherman Syndrome</keyword>
  <keyword>Abortion Late</keyword>
  <keyword>Hyaluronic acid gel</keyword>
  <keyword>Hysteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gynatresia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

